Dr. Vamsi K. Vasireddy

Claim this profile

Carle Cancer Center

Expert in Cancer
Studies Lung Cancer
30 reported clinical trials
55 drugs studied

About Vamsi K. Vasireddy


  • Earned a Medical Degree (MD) from an unspecified institution.


  • Serves as a Clinical Assistant Professor in Clinical Sciences at the University of Illinois College of Medicine.

Area of expertise

Global Leader
Vamsi K. Vasireddy has run 20 trials for Cancer. Some of their research focus areas include:
Stage IV
Stage III
Stage II
2Lung Cancer
Vamsi K. Vasireddy has run 7 trials for Lung Cancer. Some of their research focus areas include:
Stage III
Stage IV
Stage II

Affiliated Hospitals

Image of trial facility.
Carle Cancer Center
Image of trial facility.
Carle Physician Group-Effingham

Clinical Trials Vamsi K. Vasireddy is currently running

Image of trial facility.

Lomustine + Standard Therapy

for Glioblastoma

This phase III trial compares the effect of adding lomustine to temozolomide and radiation therapy versus temozolomide and radiation therapy alone in shrinking or stabilizing newly diagnosed MGMT methylated glioblastoma. Chemotherapy drugs, such as lomustine and temozolomide, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Radiation therapy uses high energy photons to kill tumor cells and shrink tumors. Adding lomustine to usual treatment of temozolomide and radiation therapy may help shrink and stabilize glioblastoma.
Recruiting2 awards Phase 34 criteria
Image of trial facility.

Atezolizumab + Chemotherapy

for Neuroendocrine Carcinoma

This phase II/III trial compares the effect of immunotherapy with atezolizumab in combination with standard chemotherapy with a platinum drug (cisplatin or carboplatin) and etoposide versus standard therapy alone for the treatment of poorly differentiated extrapulmonary (originated outside the lung) neuroendocrine cancer that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced) or that has spread from where it first started (primary site) to other places in the body (metastatic). The other aim of this trial is to compare using atezolizumab just at the beginning of treatment versus continuing it beyond the initial treatment. Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Cisplatin and carboplatin are in a class of medications known as platinum-containing compounds that work by killing, stopping or slowing the growth of cancer cells. Etoposide is in a class of medications known as podophyllotoxin derivatives. It blocks a certain enzyme needed for cell division and DNA repair, and it may kill cancer cells. Giving atezolizumab in combination with a platinum drug (cisplatin or carboplatin) and etoposide may work better in treating patients with poorly differentiated extrapulmonary neuroendocrine cancer compared to standard therapy with a platinum drug (cisplatin or carboplatin) and etoposide alone.
Recruiting1 award Phase 2 & 310 criteria

More about Vamsi K. Vasireddy

Clinical Trial Related2 years of experience running clinical trials · Led 30 trials as a Principal Investigator · 18 Active Clinical Trials
Treatments Vamsi K. Vasireddy has experience with
  • Carboplatin
  • Atezolizumab
  • Nivolumab
  • Pembrolizumab
  • Cisplatin
  • Intensity-Modulated Radiation Therapy

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Vamsi K. Vasireddy specialize in?
Vamsi K. Vasireddy focuses on Cancer and Lung Cancer. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are Stage III.
Is Vamsi K. Vasireddy currently recruiting for clinical trials?
Yes, Vamsi K. Vasireddy is currently recruiting for 18 clinical trials in Urbana Illinois. If you're interested in participating, you should apply.
Are there any treatments that Vamsi K. Vasireddy has studied deeply?
Yes, Vamsi K. Vasireddy has studied treatments such as Carboplatin, Atezolizumab, Nivolumab.
What is the best way to schedule an appointment with Vamsi K. Vasireddy?
Apply for one of the trials that Vamsi K. Vasireddy is conducting.
What is the office address of Vamsi K. Vasireddy?
The office of Vamsi K. Vasireddy is located at: Carle Cancer Center, Urbana, Illinois 61801 United States. This is the address for their practice at the Carle Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.